Article info

Download PDFPDF
An open-label study of zoledronic acid (Aclasta 5 mg iv) in the treatment of ankylosing spondylitis

Authors

  1. Correspondence to Dr GPR Clunie, Department of Rheumatology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK; gavin.clunie{at}doctors.org.uk
View Full Text

Citation

Clunie GPR, Ginawi A, O'Conner P, et al
An open-label study of zoledronic acid (Aclasta 5 mg iv) in the treatment of ankylosing spondylitis

Publication history

  • Received November 18, 2013
  • Revised January 20, 2014
  • Accepted January 24, 2014
  • First published February 12, 2014.
Online issue publication 
April 30, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.